A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas
Clinical trial NCT01512758 · COMPLETED
Trial details
- NCT number
- NCT01512758
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-06
- Primary completion
- 2013-10-08
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.